Search - Prime Therapeutics
Navigate to
-
Quarterly Drug Pipeline: January 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...
-
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
-
Star Tribune
PA Sub-Categories: GLP-1 Prime Article: In the News -
Shortages in the manufacturing chain have led to label hopping and an increase in off-label use
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
publications The evolution of GLP-1s September 1, 2024 Prime's clinical experts share their perspectives on developing a holistic, individualized strategy to capitalize on opportunities and...
-
The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime...
PA Sub-Categories: GLP-1 Prime Article: In the News -
CNN: At 37:03, listen to fitness expert Jillian Michaels cite Prime/Magellan Rx research on a podcast recording of a June 21 CNN broadcast
PA Sub-Categories: GLP-1 Prime Article: In the News -
-
Support your members with diabetes and obesity We help members navigate the challenges of diabetes and obesity with our holistic, customized approach to care. Breadcrumb Home Our solutions...
-
-
Experience pharmacy solutions built for you Get holistic, people-centered solutions that help you save money while delivering a better member experience. Breadcrumb Home Who we are About us...
-
From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights
PA Sub-Categories: GLP-1 Technology Awards Specialty drugs Prime Article: Stories -
-
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
U.S. News & World Report
PA Sub-Categories: GLP-1 Prime Article: In the News -
Read Drug Approvals Monthly Update: March 2024 Critical updates in an ever-changing environment Drug Approval Update Specialty New drugs 3/13/2024 Tevimbra™ (tislelizumab-jsgr) Tevimbra, a...
-
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News